Cargando…

Multimodal Assessment and Characterization of Sicca Syndrome

Background: Sicca syndrome represents a heterogeneous group of conditions, such as Sjögren syndrome, causing xerophthalmiaand xerostomia. This study characterizes in depth patients with Sicca syndrome and evaluates salivary gland ultrasound (SGUS). Methods: Principal component analysis and hierarchi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kramer, Emelie, Seeliger, Tabea, Skripuletz, Thomas, Gödecke, Vega, Beider, Sonja, Jablonka, Alexandra, Witte, Torsten, Ernst, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714883/
https://www.ncbi.nlm.nih.gov/pubmed/34977077
http://dx.doi.org/10.3389/fmed.2021.777599
_version_ 1784624023996465152
author Kramer, Emelie
Seeliger, Tabea
Skripuletz, Thomas
Gödecke, Vega
Beider, Sonja
Jablonka, Alexandra
Witte, Torsten
Ernst, Diana
author_facet Kramer, Emelie
Seeliger, Tabea
Skripuletz, Thomas
Gödecke, Vega
Beider, Sonja
Jablonka, Alexandra
Witte, Torsten
Ernst, Diana
author_sort Kramer, Emelie
collection PubMed
description Background: Sicca syndrome represents a heterogeneous group of conditions, such as Sjögren syndrome, causing xerophthalmiaand xerostomia. This study characterizes in depth patients with Sicca syndrome and evaluates salivary gland ultrasound (SGUS). Methods: Principal component analysis and hierarchical clustering of clinical parameters, such as ESSPRI, ESSDAI and laboratory data, were performed on all referrals for assessment of Sicca symptoms between October 2018 and March 2021. SGUS and labial gland biopsies were compared across groups. Results: A total of 583 patients were assessed. Objective dryness was confirmed in 73% of the patients. Cluster analysis identified 3 groups with post-hoc analysis confirming distinct phenotypes: Somatic Group (283/583; 49%) with more frequent symptoms but limited objective dryness; Dry Without Autoimmune Features (DAF(neg), 206/584; 35%), and Dry With Autoimmune Features (DAF(pos), 94/584;16%). DAF(pos) patients had highest autoantibody titers (anti-SSA(Ro) 240 vs. 3.6 vs. 3.8; p < 0.001), most extra-glandular manifestations (p < 0.001), and highest median SGUS Score (DAF(pos): 8 [IQR 4–10] vs. SG: 2 [1–4] vs. DAF(neg) 4 [2–5]; p < 0.001). No tangible correlation with primary Sjögren syndrome criteria was observed. Discussion: SGUS score correlated with a subset of patients with Sjögren syndrome, identified in the DAF(pos) cluster. This study highlights heterogeneity within sicca and, indeed, Sjögren syndrome, highlighting the need for further studies.
format Online
Article
Text
id pubmed-8714883
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87148832021-12-30 Multimodal Assessment and Characterization of Sicca Syndrome Kramer, Emelie Seeliger, Tabea Skripuletz, Thomas Gödecke, Vega Beider, Sonja Jablonka, Alexandra Witte, Torsten Ernst, Diana Front Med (Lausanne) Medicine Background: Sicca syndrome represents a heterogeneous group of conditions, such as Sjögren syndrome, causing xerophthalmiaand xerostomia. This study characterizes in depth patients with Sicca syndrome and evaluates salivary gland ultrasound (SGUS). Methods: Principal component analysis and hierarchical clustering of clinical parameters, such as ESSPRI, ESSDAI and laboratory data, were performed on all referrals for assessment of Sicca symptoms between October 2018 and March 2021. SGUS and labial gland biopsies were compared across groups. Results: A total of 583 patients were assessed. Objective dryness was confirmed in 73% of the patients. Cluster analysis identified 3 groups with post-hoc analysis confirming distinct phenotypes: Somatic Group (283/583; 49%) with more frequent symptoms but limited objective dryness; Dry Without Autoimmune Features (DAF(neg), 206/584; 35%), and Dry With Autoimmune Features (DAF(pos), 94/584;16%). DAF(pos) patients had highest autoantibody titers (anti-SSA(Ro) 240 vs. 3.6 vs. 3.8; p < 0.001), most extra-glandular manifestations (p < 0.001), and highest median SGUS Score (DAF(pos): 8 [IQR 4–10] vs. SG: 2 [1–4] vs. DAF(neg) 4 [2–5]; p < 0.001). No tangible correlation with primary Sjögren syndrome criteria was observed. Discussion: SGUS score correlated with a subset of patients with Sjögren syndrome, identified in the DAF(pos) cluster. This study highlights heterogeneity within sicca and, indeed, Sjögren syndrome, highlighting the need for further studies. Frontiers Media S.A. 2021-12-15 /pmc/articles/PMC8714883/ /pubmed/34977077 http://dx.doi.org/10.3389/fmed.2021.777599 Text en Copyright © 2021 Kramer, Seeliger, Skripuletz, Gödecke, Beider, Jablonka, Witte and Ernst. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Kramer, Emelie
Seeliger, Tabea
Skripuletz, Thomas
Gödecke, Vega
Beider, Sonja
Jablonka, Alexandra
Witte, Torsten
Ernst, Diana
Multimodal Assessment and Characterization of Sicca Syndrome
title Multimodal Assessment and Characterization of Sicca Syndrome
title_full Multimodal Assessment and Characterization of Sicca Syndrome
title_fullStr Multimodal Assessment and Characterization of Sicca Syndrome
title_full_unstemmed Multimodal Assessment and Characterization of Sicca Syndrome
title_short Multimodal Assessment and Characterization of Sicca Syndrome
title_sort multimodal assessment and characterization of sicca syndrome
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714883/
https://www.ncbi.nlm.nih.gov/pubmed/34977077
http://dx.doi.org/10.3389/fmed.2021.777599
work_keys_str_mv AT krameremelie multimodalassessmentandcharacterizationofsiccasyndrome
AT seeligertabea multimodalassessmentandcharacterizationofsiccasyndrome
AT skripuletzthomas multimodalassessmentandcharacterizationofsiccasyndrome
AT godeckevega multimodalassessmentandcharacterizationofsiccasyndrome
AT beidersonja multimodalassessmentandcharacterizationofsiccasyndrome
AT jablonkaalexandra multimodalassessmentandcharacterizationofsiccasyndrome
AT wittetorsten multimodalassessmentandcharacterizationofsiccasyndrome
AT ernstdiana multimodalassessmentandcharacterizationofsiccasyndrome